Brent Sabatini, CAO of Vir Biotechnology VIR, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $113.1K. The latest trade was on 06/01.

BS

BS

Brent Sabatini

SVP, Chief Accounting Officer

Company

Vir Biotechnology VIR

First filing

25/02/13

Trades

11 trades

Buys / sales

0 / 7

12-month net buying

−$113.1K

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	06/01	06/02	379 sh	$9.45	$3,581.55	−0.6%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	03/23	03/24	7,711 sh	$9.12	$70,324.32	−11.1%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	02/24	02/26	1,430 sh	$9.53	$13,627.9	−2.0%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	02/23	02/24	1,829 sh	$7.45	$13,626.05	−2.5%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	02/13	02/18	1,530 sh	$7.79	$11,918.7	−3.1%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	25/02/24	25/02/25	1,562 sh	$9.45	$14,760.9	−3.2%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	25/02/13	25/02/14	1,562 sh	$9.15	$14,292.3	−5.3%